Related Experiment Videos
Maternal weight correction for alpha-fetoprotein: mathematical truncations revisited
Mark I Evans1, Harold Harrison, Joseph E O'Brien
1Department of Obstetrics and Gynecology, MCP Hahnemann University, Philadelphia, PA 19102, USA. obchair@drexel.edu
Genetic Testing
|December 20, 2002
Summary
Maternal weight correction for alpha-fetoprotein (AFP) testing needs updating. A 200 lbs. cutoff optimizes AFP test distribution, improving accuracy for prenatal screening.
Area of Science:
- Biochemistry
- Prenatal Diagnostics
- Medical Screening
Background:
- Alpha-fetoprotein (AFP) testing is a crucial component of prenatal screening.
- Current maternal weight correction methods for AFP testing were established two decades ago.
- The appropriateness of existing weight correction protocols requires re-evaluation.
Purpose of the Study:
- To assess the continued validity of maternal weight correction for AFP testing.
- To determine the optimal maternal weight cutoff for AFP measurement adjustments.
- To enhance the uniformity and accuracy of AFP screening across different maternal weights.
Main Methods:
- Analysis of 44,951 AFP screening cases from a single laboratory.
- Division of AFP measurements by maternal weight.
- Categorization of results into high (≥2.5 multiples of the median - MOM) and low (<0.4 MOM) levels.
- Comparison of AFP distribution using different maternal weight truncation points (200 lbs. vs. 250 lbs.).
Main Results:
- Without weight correction, higher maternal weight is associated with lower AFP levels.
- Truncating maternal weight at 200 lbs. yields more uniform AFP distributions compared to a 250 lbs. cutoff.
- A 200 lbs. cutoff optimizes the distribution of both high and low AFP values, reducing overcompensation seen with a 250 lbs. cutoff.
Conclusions:
- The existing maternal weight correction for AFP testing is outdated.
- A maternal weight cutoff of 200 lbs. provides a more equitable and accurate distribution of AFP test results.
- Implementing a 200 lbs. cutoff can improve the reliability of prenatal screening.